KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stryker (SYK) Payables (2016 - 2025)

Historic Payables for Stryker (SYK) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Stryker's Payables rose 685.34% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 685.34%. This contributed to the annual value of $2.1 billion for FY2025, which is 685.34% up from last year.
  • As of Q4 2025, Stryker's Payables stood at $2.1 billion, which was up 685.34% from $1.8 billion recorded in Q3 2025.
  • Over the past 5 years, Stryker's Payables peaked at $2.1 billion during Q4 2025, and registered a low of $1.0 billion during Q1 2021.
  • Its 5-year average for Payables is $1.6 billion, with a median of $1.6 billion in 2023.
  • As far as peak fluctuations go, Stryker's Payables skyrocketed by 3580.53% in 2021, and later crashed by 605.69% in 2024.
  • Stryker's Payables (Quarter) stood at $1.4 billion in 2021, then grew by 21.91% to $1.7 billion in 2022, then rose by 7.31% to $1.8 billion in 2023, then grew by 9.77% to $2.0 billion in 2024, then increased by 6.85% to $2.1 billion in 2025.
  • Its Payables was $2.1 billion in Q4 2025, compared to $1.8 billion in Q3 2025 and $1.8 billion in Q2 2025.